Company now expects to complete enrollment of 150 patients in Q2 2026, with a Phase 3 data readout in mid-2027; Rolling NDA ...

Sanofi’s Teizeild approved in the EU for patients with stage 2 type 1 diabetesApproval based on the TN-10 phase 2 study that demonstrated a ...

The levels of caffeine in your blood could affect the amount of body fat you carry, a factor that in turn could determine ...

Breaking down the new 2025-2030 U.S. Dietary Guidelines: why the new recommendation is to "consume less alcohol for better ...

In this phase 3 trial, researchers aimed to study the efficacy of tumor bed boost and moderately hypofractionated whole breast irradiation in patients with non-low-risk DCIS.

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Clinical research technology veteran joins to accelerate company's growth as the unified platform solution for ...

A prospective study of 39 mother-infant dyads exposed to SARS-CoV-2 during pregnancy suggested that cognitive skills in ...

Global and genetic analyses link low physical activity to rising heart disease mortality, while higher activity levels appear ...

A new study provides novel insights into the durability of endovascular thrombectomy in patients with stroke caused by ...

In the end randomization did not save us much time.” Larian will continue iterating on its existing Divinity Engine for the next game. It’s not suddenly moving to Unreal like some other RPG studios.